Autologous Hematopoietic Stem Cell Transplantation May Be Highly Effective Treatment for Severe, Treatment Refractory Stiff Person Syndrome (S31.007)
George E. Georges(Northwestern University), Richard A. Nash(Colorado Blood Cancer Institute), Michael Pearlman(Sarah Cannon), Joel Sytsma(Fred Hutch Cancer Center), James D. Bowen(Swedish Medical Center), Michael D. Weiss(University of Washington), B McLaughlin(Fred Hutch Cancer Center), Peter A. McSweeney(Mesoblast (United States)), Annette Wundes(University of Washington Medical Center), George H. Kraft(Patara Pharma (United States)), Gloria von Geldern(University of Washington)
Cited by 4
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k